No medical condition.

• Bioequivalence study of two sulodexide preparations: Sulodexide Intexo 250 LRU and Vessel Due F 250 LRU cps Pending
  2024-515605-26-00 2
• Bioequivalence of Lisdexamfetamine dimesylate 10 mg Capsules in Healthy Participants Under Fasting Conditions. Pending
  2024-517732-21-00 2
• Single-Dose Study in Healthy Participants to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One F … Recruiting
  2026-526040-13-00 2 2026-05-25
• Comparative Bioavailability of Levonorgestrel 52 mg Intrauterine System versus Mirena® in Healthy Pre-Menopausal, Non-Pregnant Female Partic … Recruiting
  2025-523736-39-00 2 2025-12-29
• Multiple-Dose Study in Healthy Participants Under Fasting Conditions to Evaluate the Bioequivalence of One Film-Coated Mini-Tablet of Indapa … Recruitment ended
  2026-525823-26-00 2 2026-04-25
• Multiple-Dose Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Recruitment ended
  2025-522627-10-00 2 2026-04-20
• Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fed Conditions. Recruitment ended
  2025-522624-27-00 2 2026-04-15
• Safety and tolerability of medicated chewing gum with sodium alginate, calcium carbonate and sodium bicarbonate. Ended
  2025-524102-15-00 3 2026-04-29
• Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Ended
  2025-522626-12-00 2 2025-12-18
• Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin. Ended
  2024-519851-27-00 2 2025-12-09
• Bioequivalence of Cinnarizine/Dimenhydrinate 20 mg/40 mg Tablets in Healthy Participants Under Fed Conditions. Ended
  2025-523948-12-00 2 2025-11-27
• Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin. Ended
  2024-519849-29-00 2 2025-10-27
• Multiple-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Participants. Ended
  2025-523419-12-00 3 2025-10-15
• Evaluating Bioequivalence of a Fixed Dose Combination versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin. Ended
  2024-519852-10-00 2 2025-09-10
• Evaluation of the Effect of Food, Itraconazole, and Rifampicin on the Single-Dose Pharmacokinetics of Naronapride. Ended
  2024-520215-40-00 3 2025-09-09
• Bioequivalence of Canagliflozin 300 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions. Ended
  2024-519109-36-00 2 2025-07-09
• Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants. Ended
  2025-520737-23-00 2 2025-07-07
• Bioequivalence of One Tablet of Gliclazide MR 90 mg (S005190) and One and a Half Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy P … Ended
  2024-519567-18-00 2 2025-06-02
• Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participant … Ended
  2024-519470-39-00 2 2025-05-30
• Investigate Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Tampons and Lubricants in Healthy Female Partic … Ended
  2025-520517-32-00 3 2025-05-29
• Investigation of Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Miconazole in Healthy Female Participants. Ended
  2025-520516-33-00 3 2025-05-28
• Bioequivalence of One Tablet of Gliclazide MR 120 mg (S005190) and Two Tablets of Gliclazide MR 60 mg (Diamicron® MR) in Healthy Participant … Ended
  2024-519250-37-00 2 2025-05-27
• Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227 Ended
  2024-518734-87-00 3 2025-03-25
• Bioequivalence of Ruxolitinib 25 mg Tablets in Healthy Participants Under Fasting Conditions Ended
  2025-520716-34-00 2 2025-03-17

Showing 1–24 of 54 trials